Company Information
CIN
Status
Date of Incorporation
23 November 2010
State / ROC
Mumbai / ROC Mumbai
Last Balance Sheet
31 March 2016
Last Annual Meeting
30 September 2016
Paid Up Capital
100,000
Authorised Capital
100,000
Directors
Abhishek Ranvir Singh
Director
over 2 years ago
over 2 years ago
Sudheer Singh
Additional Director
about 8 years ago
about 8 years ago
Past Directors
Sushma Singh
Director
about 15 years ago
about 15 years ago
Ranvir Kumar Bindeshwari Singh
Director
about 15 years ago
about 15 years ago
Patents
The present invention relates generally to the fields of proteins, diagnostics, therapeutics and nutrition. More particularly, the present invention provides an isolated protein molecule in or related to the IL-6 protein family such as G-CSF, IL-11, IL-6, LIF or chimeric molecules thereof, comprising at least a port...
The present invention relates generally to the fields of proteins, diagnostics, therapeutics and nutrition. More particularly, the present invention provides an isolated protein molecule in or related to the tumour necrosis factor (TNF) superfamily such as TNF-a, Lymphotoxin-a (LT-a), TNFRI, TNFRII, OX40, BAFF, NGFR...
A method for generating a sequence of concealment samples in connection with transmission of a digitized audio signal, wherein the method comprises generating the sequence of concealment samples from buffered samples of the digitized representation of audio signal in sample time order, wherein at least two consecuti...
The present invention relates generally to the fields of proteins, diagnostics therapeutics and nutrition. More particularly, the present invention provides an isolated protein molecule in or related to the IL-2 protein family such as IL-2, IL-2Ra, IL-2Rb, IL-2Rg or chimeric molecules thereof, such as IL-2-Fc, IL-2R...
The present invention relates generally to the fields of proteins, diagnostics, therapeutics and nutrition. More particularly, the present invention provides an isolated protein molecule that comprises a dimeric 4-helix bundle, such as IFN-a2B, IFN-b1, IFN-g, IL-10 or its receptor, such as IFNAR2, IL-10Ra or chimeri...
The present invention relates generally to the fields of proteins, diagnostics, therapeutics and nutrition. More particularly, the present invention provides an isolated protein molecule in or related to the short chain 4 helix bundle superfamily such as GM-CSF, IL-3, IL-4 and IL-5 or chimeric molecules thereof comp...
Documents
Form DIR-12-29102017_signed
Declaration by first director-26102017
Declaration of the appointee director, Managing director, in Form No. DIR-2;-26102017
Evidence of cessation;-26102017
Form DIR-12-26102017_signed
Letter of appointment;-26102017
Notice of resignation;-26102017
Form AOC-4-13122016_signed
Form MGT-7-01122016_signed
List of share holders, debenture holders;-30112016
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-29112016
Directors report as per section 134(3)-29112016
Form AOC-4-300116.OCT
Form ADT-1-280116.OCT
Form MGT-7-280116.OCT
Form23AC-170415 for the FY ending on-310314.OCT
Form23AC-031114 for the FY ending on-310313.OCT
Form 32-170114.OCT
Optional Attachment 1-170114.PDF
Evidence of cessation-170114.PDF
Investor Complaint Form-071113.PDF
Complaint non filing of return of cessation-071113.PDF
FormSchV-280813 for the FY ending on-310311.OCT
Form23AC-280813 for the FY ending on-310311.OCT
Investor Complaint Form-300713.PDF
Optional Attachment 1-300713.PDF
Investor Complaint Form-240713.PDF
Optional Attachment 1-240713.PDF
Investor Complaint Form-170413.PDF
Optional Attachment 1-170413.PDF
